Company intelligence / Profile preview

AXIM Biotechnologies, Inc.

San Diego, California, United Statesaximbiotech.com ↗

Ownership: Public · AXIM
Employees: ~7
Development stage: Commercial

Overview

AXIM currently has two FDA-cleared ocular diagnostic assays: T-POC TOTAL IgE Immunoassay and T-POC LACTOFERRIN Immunoassay Kits, which address unmet needs in dry eye diagnosis and treatment planning

Therapeutic areas: OphthalmologyGastroenterologyDermatologyNeurology
Modalities: Diagnostic assaysCannabinoid-based products (historical)
Industry: Protein Biomarker Diagnostics

Partnerships

Verséa Ophthalmics

Financials

Market cap: $1.4M
Total revenue: $207K
Enterprise value: $9.1M

Beyond the preview

Go deeper on AXIM Biotechnologies, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AXIM Biotechnologies, Inc..

Explore the full profile